Sixty seconds on . . . pre-exposure prophylaxisBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6415 (Published 02 December 2015) Cite this as: BMJ 2015;351:h6415
- Nigel Hawkes
I love a medicoethical dilemma
Then here’s one. Should the NHS in England spend up to £4500 (€6400; $6800) a year per patient providing a pre-exposure prophylaxis (PrEP) drug to healthy gay men and injecting drug users so that they can lower their risk of being infected with HIV?
Is there any advantage over condoms in taking a drug to reduce the risk from sex?
That is the heart of the dilemma. Some right wing columnists …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial